PTPRC and neoplasm: The modulation of PTPRC (CD45) suggests enhanced leukocyte activity, which is vital for initiating and sustaining an anti-tumor immune response (Li P. et al., 2023; Salmond, 2024; Wong et al., 2013; Yang and Klein, 2022).